1Rustin GJ,Quinn M,Thigpen T,et al.Re:new guidelines to evaluate the response to treatment in solid tumors (ovarian cancer).J Natl cancer Inst,2004,96(6):487-488.
2Vergote I,Rustin GJ,Eisenhauer EA,et al.New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer) gynecologic cancer intergroup.J Natl Cancer Inst,2000,92(18):1534-1535.
3Moufarij MA,Phillips DR,Cullinane C.Gemcitabine potentiates cisplatin cytotoxicity and inhibits repair of cisplatin-DNA damage in ovarian cancer cell lines.Mol Pharmacol,2003,63 (4):862-869.
4Rose PG,Mossbruger K,Fusco N,et al.Gemcitabine reverses cisplatin resistance:demonstration of activity in platinum-and multidrug-resistant ovarian and peritoneal carcinoma.Gynecol Oncol,2003,88 (1):17-21.
9Siegel R, Naishadham D, Jemal A. Cancer statistics,2013 [ J] . CACancer J Clin,2013,63( 1) : 11 -30.
10Salzberg M , Thurlimann B, Bonnefois H, et al. Current concepts oftreatment strategies in advanced or recurrent ovarian cancer [ J ].()ncotogy,2005,68(4 -6) :293 -298.
